Enforcement record
The government paper trail.
Public FDA warning letters and import alerts, DOJ prosecutions, FTC actions, and recalls affecting peptide and research-chemical sellers. Every entry is a real government record with its source linked. We report the action — we never add an accusation of our own, and a match to a specific vendor is only made when we’re confident.
396
Actions on record
5
Severe (proven)
3
Tracked vendors affected
2
Agencies
Showing 1–3 of 3.
FDA · Warning letter · 2025-09-08
FDA warning letter — unapproved tianeptine products
Named: PureRawz (Seann Gloss) · matched to PureRawz
FDA reviewed purerawz.co in August 2025 and found multiple Tianeptine products; despite 'for laboratory and research use only' labeling, FDA deemed them unapproved new drugs intended for human use.
FDA · Warning letter · 2024-12-10
FDA warning letter — unapproved new drugs (semaglutide, retatrutide)
Named: Swisschems · matched to Swiss Chems
FDA reviewed swisschems.is in October 2024 and found it offered 'Semaglutide' and 'Retatrutide' for sale in the U.S. Despite 'research chemicals only' labeling, FDA determined these are unapproved new drugs under the FD&C Act.
FDA · Warning letter · 2021-05-18
FDA warning letter — SARMs and undeclared tadalafil
Named: Umbrella (Brendan Mullins) · matched to Umbrella Labs
FDA found the firm's sites directed consumers to umbrellalabs.is selling SARMs (GW-501516, MK-2866, MK-677, RAD-140, S-4), plus tianeptine and kratom; lab analysis found 'Alpha Male Plus' contained undeclared tadalafil. Deemed unapproved/misbranded drugs.
A record is a fact, not a verdict on the product.
An FDA warning letter usually means a seller marketed unapproved drugs — it doesn’t always mean the specific product you’re looking at is impure. We show the record and the source so you can judge; we distinguish a proven criminal outcome from a mere charge, and a warning letter from a conviction. We never infer guilt VialGrade cannot source.